TriSalus Life Sciences (TLSI) Goodwill & Intangibles (2022 - 2024)
TriSalus Life Sciences' (TLSI) quarterly Goodwill & Intangibles came in at $1.1 million in Q2 2024, little changed quarter-over-quarter from $1.1 million in Q1 2024.
TriSalus Life Sciences (TLSI) Goodwill & Intangibles (2022 - 2024) Analysis & Trends
TriSalus Life Sciences' Goodwill & Intangibles history runs 3 years deep, the most recent figure standing at $1.1 million for Q2 2024.
- On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $1.1 million in Q2 2024; TTM through Jun 2024 was $1.1 million, a N/A change from a year earlier, with the FY2023 full-year figure at $1.1 million, up 40.52% from the prior year.
- Goodwill & Intangibles held at $1.1 million in Q2 2024 per TLSI's latest filing, from $1.1 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $1.1 million in Q4 2023 and bottomed at $802000.0 in Q4 2022.
- The 3-year median for Goodwill & Intangibles is $1.1 million (2024), against an average of $1.0 million.
- Biggest YoY gain for Goodwill & Intangibles was 40.52% in 2023; the steepest drop was 40.52% in 2023.
- Year by year, Goodwill & Intangibles stood at $802000.0 in 2022, then soared by 40.52% to $1.1 million in 2023, then retreated by 1.24% to $1.1 million in 2024.
- Per Business Quant, the three latest TLSI Goodwill & Intangibles figures stand at $1.1 million (Q2 2024), $1.1 million (Q1 2024), and $1.1 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 997,000.00 |
| Dec 31, 2022 | 802,000.00 |